161 related articles for article (PubMed ID: 15262134)
21. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of the expression of endogenous Mdr1 P-glycoprotein enhances lipid translocation in MDCK cells transfected with human MRP2.
Raggers RJ; Vogels I; van Meer G
Histochem Cell Biol; 2002 Feb; 117(2):181-5. PubMed ID: 11935294
[TBL] [Abstract][Full Text] [Related]
23. [Clinical correlations of multidrug resistance gene expression in ovarian carcinoma].
Chen X; Li L; Huang W
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):652-5. PubMed ID: 9387523
[TBL] [Abstract][Full Text] [Related]
24. MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer.
Roy S; Kenny E; Kennedy S; Larkin A; Ballot J; Perez De Villarreal M; Crown J; O'Driscoll L
Anticancer Res; 2007; 27(3A):1325-30. PubMed ID: 17593626
[TBL] [Abstract][Full Text] [Related]
25. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
[TBL] [Abstract][Full Text] [Related]
26. Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer.
Hille S; Rein DT; Riffelmann M; Neumann R; Sartorius J; Pfützner A; Kurbacher CM; Schöndorf T; Breidenbach M
Anticancer Drugs; 2006 Oct; 17(9):1041-4. PubMed ID: 17001177
[TBL] [Abstract][Full Text] [Related]
27. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer.
Naniwa J; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Shimogai R; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2007; 17(1):76-82. PubMed ID: 17291235
[TBL] [Abstract][Full Text] [Related]
28. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
[TBL] [Abstract][Full Text] [Related]
29. Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
Cornarotti M; Capranico G; Bohm S; Oriana S; Spatti GB; Mariani L; Ballabio G; Zunino F
Int J Cancer; 1996 Aug; 67(4):479-84. PubMed ID: 8759604
[TBL] [Abstract][Full Text] [Related]
30. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.
Giessmann T; May K; Modess C; Wegner D; Hecker U; Zschiesche M; Dazert P; Grube M; Schroeder E; Warzok R; Cascorbi I; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2004 Sep; 76(3):192-200. PubMed ID: 15371980
[TBL] [Abstract][Full Text] [Related]
31. MDR1, MRP1 and MRP2 genotypes and in vitro chemosensitivity in Japanese patients with colorectal adenocarcinomas.
Nishioka C; Sakaeda T; Nakamura T; Moriya Y; Okamura N; Tamura T; Nakahara T; Aoyama N; Kamigaki T; Ohno M; Kuroda Y; Kasuga M; Okumura K
Kobe J Med Sci; 2004; 50(5-6):181-8. PubMed ID: 16107775
[TBL] [Abstract][Full Text] [Related]
32. [Methylated oligonucleotide inhibiting expression of human MRP2 and reversing multidrug resistance in hepatocellular carcinoma Cell HepG2].
Li WH; Cui Y; Zhu JR
Ai Zheng; 2004 Aug; 23(8):900-4. PubMed ID: 15301711
[TBL] [Abstract][Full Text] [Related]
33. RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.
Materna V; Stege A; Surowiak P; Priebsch A; Lage H
Biochem Biophys Res Commun; 2006 Sep; 348(1):153-7. PubMed ID: 16876126
[TBL] [Abstract][Full Text] [Related]
34. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.
Rau S; Autschbach F; Riedel HD; Konig J; Kulaksiz H; Stiehl A; Riemann JF; Rost D
Eur J Clin Invest; 2008 Feb; 38(2):134-42. PubMed ID: 18226047
[TBL] [Abstract][Full Text] [Related]
35. Clinical relationship between MDR1 gene and gallbladder cancer.
Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
[TBL] [Abstract][Full Text] [Related]
36. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
37. [A case of malignant meningioma treated by individual adjuvant chemotherapy based on the mRNA expression of drug-resistance gene].
Kunishio K; Kobayashi K; Kagawa M; Makabe T; Matsumoto A; Matsumoto Y
Gan To Kagaku Ryoho; 2007 Feb; 34(2):265-8. PubMed ID: 17301541
[TBL] [Abstract][Full Text] [Related]
38. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance.
Yang L; Li N; Wang H; Jia X; Wang X; Luo J
Oncol Rep; 2012 Aug; 28(2):592-600. PubMed ID: 22614869
[TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.
van der Zee AG; Hollema H; de Jong S; Boonstra H; Gouw A; Willemse PH; Zijlstra JG; de Vries EG
Cancer Res; 1991 Nov; 51(21):5915-20. PubMed ID: 1682037
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid.
Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I
Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
